Creating a human out of chemicals in a laboratory may sound like something from a horror movie, but it is an idea that some scientists are exploring, quietly behind closed doors.
Earlier this week, approximately 150 medical researchers, lawyers, and entrepreneurs met in secret at Harvard Medical School to discuss the possibility of creating an entirely synthetic human genome.
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
The invitation-only meeting was held in Boston on Tuesday The New York Times reports and attendees were told not to contact the media about it:
Scientists are now contemplating the fabrication of a human genome, meaning they would use chemicals to manufacture all the DNA contained in human chromosomes.
The prospect is spurring both intrigue and concern in the life sciences community because it might be possible, such as through cloning, to use a synthetic genome to create human beings without biological parents.
While the project is still in the idea phase, and also involves efforts to improve DNA synthesis in general, it was discussed at a closed-door meeting on Tuesday at Harvard Medical School in Boston. The nearly 150 attendees were told not to contact the news media or to post on Twitter during the meeting.
Organizers said the project could have a big scientific payoff and would be a follow-up to the original Human Genome Project, which was aimed at reading the sequence of the three billion chemical letters in the DNA blueprint of human life. The new project, by contrast, would involve not reading, but rather writing the human genome — synthesizing all three billion units from chemicals.
But such an attempt would raise numerous ethical issues. Could scientists create humans with certain kinds of traits, perhaps people born and bred to be soldiers? Or might it be possible to make copies of specific people?
“Would it be O.K., for example, to sequence and then synthesize Einstein’s genome?” Drew Endy, a bioengineer at Stanford, and Laurie Zoloth, a bioethicist at Northwestern University, wrote in an essay criticizing the proposed project. “If so how many Einstein genomes should be made and installed in cells, and who would get to make them?”
Dr. Endy, though invited, said he deliberately did not attend the meeting at Harvard because it was not being opened to enough people and was not giving enough thought to the ethical implications of the work.
George Church, a professor of genetics at Harvard Medical School and an organizer of the proposed project, said there had been a misunderstanding. The project was not aimed at creating people, just cells, and would not be restricted to human genomes, he said. Rather it would aim to improve the ability to synthesize DNA in general, which could be applied to various animals, plants and microbes.
“They’re painting a picture which I don’t think represents the project,” Dr. Church said in an interview.
He said the meeting was closed to the news media, and people were asked not to tweet because the project organizers, in an attempt to be transparent, had submitted a paper to a scientific journal. They were therefore not supposed to discuss the idea publicly before publication. He and other organizers said ethical aspects have been amply discussed since the beginning.
The project was initially called HGP2: The Human Genome Synthesis Project, with HGP referring to the Human Genome Project. An invitation to the meeting at Harvard said that the primary goal “would be to synthesize a complete human genome in a cell line within a period of 10 years.”
But by the time the meeting was held, the name had been changed to “HGP-Write: Testing Large Synthetic Genomes in Cells.”
Latest posts by Niamh Harris (see all)
- Russia Says US Actively Transferring Biowarfare Projects From Ukraine To Other Regions - February 1, 2023
- Zelensky Ordered Destruction Of All Info On Hunter Biden’s Metabiota Company Same Day As Russia Invaded Ukraine - February 1, 2023
- Biden Sending $2.2 Billion In Military Aid, Including Longer-Range Weapons, To Ukraine - February 1, 2023